Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Linde plc, consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable 2,810 2,646 2,593 2,446 2,507 2,845 2,859 2,885 3,020 2,750 2,977 2,941 2,995 3,067 3,360 3,387 3,503 3,069 3,143 2,945
Short-term debt 4,510 4,962 4,879 4,465 4,223 3,509 3,326 4,046 4,713 3,849 3,018 5,337 4,117 3,179 3,215 2,549 1,163 2,895 3,681 3,276
Current portion of long-term debt 1,796 2,371 1,340 1,824 2,057 1,278 1,261 1,046 1,263 922 944 1,696 1,599 1,551 1,651 1,074 1,709 2,293 1,827 2,524
Contract liabilities 1,231 1,279 1,261 1,196 1,194 1,727 1,767 1,827 1,901 1,985 3,246 3,070 3,073 2,902 2,933 3,035 2,940 2,213 1,787 1,863
Other current liabilities 4,851 4,934 4,641 4,554 4,563 4,690 4,291 4,585 4,820 4,656 4,367 4,741 4,695 4,362 4,136 4,461 4,328 4,288 4,238 4,419
Current liabilities 15,198 16,192 14,714 14,485 14,544 14,049 13,504 14,389 15,717 14,162 14,552 17,785 16,479 15,061 15,295 14,506 13,643 14,758 14,676 15,027
Long-term debt, excluding current portion 20,683 18,592 19,701 17,608 15,343 17,475 16,931 15,227 13,397 13,232 13,528 11,744 12,198 10,608 11,177 12,833 11,335 11,539 9,984 9,950
Other long-term liabilities 11,195 11,123 11,677 11,148 10,772 10,419 10,229 10,502 10,602 10,195 9,390 9,443 9,594 9,715 10,373 11,038 11,186 12,157 12,457 12,383
Long-term liabilities 31,878 29,715 31,378 28,756 26,115 27,894 27,160 25,729 23,999 23,427 22,918 21,187 21,792 20,323 21,550 23,871 22,521 23,696 22,441 22,333
Total liabilities 47,076 45,907 46,092 43,241 40,659 41,943 40,664 40,118 39,716 37,589 37,470 38,972 38,271 35,384 36,845 38,377 36,164 38,454 37,117 37,360
Redeemable noncontrolling interests 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13
Ordinary shares, €0.001 par value 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Additional paid-in capital 39,430 39,405 39,411 39,408 39,603 39,573 39,560 39,570 39,812 39,803 39,797 39,859 40,005 40,011 39,978 39,972 40,180 40,220 40,200 40,192
Retained earnings 16,608 15,796 14,595 13,545 12,634 11,585 10,721 9,708 8,845 7,940 7,024 6,092 20,541 19,845 19,159 19,387 18,710 18,240 17,820 17,563
Accumulated other comprehensive loss (6,233) (6,409) (6,250) (6,768) (6,894) (6,059) (6,794) (6,528) (5,805) (6,676) (5,899) (5,810) (5,782) (8,094) (6,466) (4,938) (5,048) (5,618) (4,908) (5,345)
Treasury shares, at cost (11,561) (10,177) (9,242) (8,154) (7,252) (5,927) (5,309) (3,922) (3,133) (2,169) (1,011) (171) (14,737) (14,135) (12,998) (11,459) (9,808) (8,520) (7,336) (6,201)
Total Linde plc shareholders’ equity 38,245 38,616 38,515 38,032 38,092 39,173 38,179 38,829 39,720 38,898 39,911 39,970 40,028 37,628 39,674 42,963 44,035 44,323 45,777 46,210
Noncontrolling interests 1,483 1,457 1,458 1,418 1,383 1,417 1,359 1,387 1,362 1,327 1,324 1,353 1,346 1,298 1,353 1,414 1,393 1,401 1,438 1,410
Total equity 39,728 40,073 39,973 39,450 39,475 40,590 39,538 40,216 41,082 40,225 41,235 41,323 41,374 38,926 41,027 44,377 45,428 45,724 47,215 47,620
Total liabilities and equity 86,817 85,993 86,078 82,704 80,147 82,546 80,215 80,347 80,811 77,827 78,718 80,308 79,658 74,323 77,885 82,767 81,605 84,191 84,345 84,993

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The balance sheet reveals notable shifts in the company’s liabilities and stockholders’ equity between March 2021 and December 2025. Overall, total liabilities and equity experienced fluctuations, with a general increase observed towards the end of the period. A detailed examination of specific liability and equity components provides further insight.

Current Liabilities
Current liabilities generally remained relatively stable between March 2021 and June 2022, fluctuating around the US$14-15 billion range. A significant increase occurred in December 2022, reaching US$16.479 billion, before decreasing to US$14.389 billion by March 2024. A subsequent rise is observed through December 2025, reaching US$15.198 billion. Accounts payable remained relatively consistent, generally between US$2.5 billion and US$3.5 billion, with a decreasing trend in the latter part of the period. Short-term debt exhibited more volatility, peaking at US$5.337 billion in March 2022, and then fluctuating before settling around US$4.5 billion by December 2025. Contract liabilities showed an increasing trend until September 2023, then decreased significantly, stabilizing around US$1.2 billion. Other current liabilities remained consistently high, fluctuating between US$4.1 billion and US$4.9 billion.
Long-Term Liabilities
Long-term debt, excluding the current portion, demonstrated an upward trend from US$9.950 billion in March 2021 to US$17.608 billion in December 2025, with some intermediate fluctuations. Other long-term liabilities remained relatively stable between US$10 billion and US$12.5 billion until 2023, after which it showed a slight increase, reaching US$11.195 billion by December 2025. Total long-term liabilities followed a similar pattern to long-term debt, increasing from US$22.333 billion to US$31.878 billion over the analyzed period.
Stockholders’ Equity
Total stockholders’ equity experienced a decline from US$47.620 billion in March 2021 to US$38.245 billion in December 2025. Retained earnings, a significant component of equity, decreased substantially from US$17.563 billion to US$16.608 billion over the same period. Accumulated other comprehensive loss increased in absolute value, moving from -US$5.345 billion to -US$6.233 billion, contributing to the overall decline in equity. Treasury shares also increased significantly in absolute value, from -US$6.201 billion to -US$11.561 billion, further reducing equity. Redeemable noncontrolling interests remained constant throughout the period.
Total Liabilities and Equity
The initial decrease in total liabilities and equity from US$84.993 billion in March 2021 to US$81.605 billion in December 2021 was followed by a period of fluctuation. A peak of US$86.078 billion was reached in June 2025, before decreasing slightly to US$86.817 billion by December 2025. This overall trend suggests a shift in the company’s capital structure, with a relative increase in liabilities and a decrease in equity.

In summary, the company experienced a notable increase in long-term debt and a corresponding decrease in stockholders’ equity over the analyzed period. While current liabilities showed some volatility, they remained relatively stable overall. The changes in retained earnings and treasury shares significantly impacted the equity position. These trends warrant further investigation to understand the underlying drivers and potential implications for the company’s financial health.